These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. A report from the 31st European Society of Medical Oncology congress. Rabasseda X Timely Top Med Cardiovasc Dis; 2006 Nov; 10():E32. PubMed ID: 17380215 [No Abstract] [Full Text] [Related]
83. Default Options: Opportunities to Improve Quality and Value in Oncology. Ojerholm E; Halpern SD; Bekelman JE J Clin Oncol; 2016 Jun; 34(16):1844-7. PubMed ID: 26884581 [No Abstract] [Full Text] [Related]
84. Oncology trials--the elephant in the room. Kirk R; Hutchinson L Nat Rev Clin Oncol; 2012 Mar; 9(4):185-6. PubMed ID: 22456332 [No Abstract] [Full Text] [Related]
85. Commentary: contexts and challenges in pediatric psychosocial oncology research: chasing moving targets and embracing "good news" outcomes. Phipps S J Pediatr Psychol; 2005; 30(1):41-5. PubMed ID: 15610983 [No Abstract] [Full Text] [Related]
86. Mathematical Oncology. Anderson ARA; Maini PK Bull Math Biol; 2018 May; 80(5):945-953. PubMed ID: 29679280 [No Abstract] [Full Text] [Related]
88. Epilogue: the peril and the promise of comparative effectiveness research in oncology. Lyman GH; Levine M J Clin Oncol; 2012 Dec; 30(34):4282. PubMed ID: 23071238 [No Abstract] [Full Text] [Related]
89. Thirty years into the genomics era: tumor viruses led the way. DiMaio D; Miller G Yale J Biol Med; 2006 Dec; 79(3-4):179-85. PubMed ID: 17940630 [No Abstract] [Full Text] [Related]
90. Rapidly changing endocrine oncology research: personal reflection of the past, present and future times. Culig Z Endocr Relat Cancer; 2013 Apr; 20(2):P7-9. PubMed ID: 23193071 [No Abstract] [Full Text] [Related]
91. Genetics is coming to oncology. Livingston DM JAMA; 1997 May; 277(18):1476-7. PubMed ID: 9145722 [No Abstract] [Full Text] [Related]
94. Most laboratory cancer studies cannot be replicated, study shows. Hawkes N BMJ; 2012 Apr; 344():e2555. PubMed ID: 22491749 [No Abstract] [Full Text] [Related]
95. Neuro-oncology: setting new standards of management. Graus F; Tortosa A Lancet Neurol; 2006 Jan; 5(1):8-9. PubMed ID: 16361010 [No Abstract] [Full Text] [Related]
96. Epigenetic therapy in cancer: perspective and paradoxes. Filosa A; Fabiani A Anal Quant Cytol Histol; 2011 Oct; 33(5):303-4. PubMed ID: 22611759 [No Abstract] [Full Text] [Related]
97. Standardisation and outcomes audit: a step forward in surgical oncology. González-Moreno S Clin Transl Oncol; 2010 Jun; 12(6):389-90. PubMed ID: 20534391 [No Abstract] [Full Text] [Related]
99. Improving cancer research in older adults. The UK National Cancer Research Institute initiative. Simcock R J Geriatr Oncol; 2019 May; 10(3):382-383. PubMed ID: 30765269 [No Abstract] [Full Text] [Related]
100. Editorial. Various approaches in the field of cancer therapy. Zaman K Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):1-3. PubMed ID: 22122268 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]